MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Dyspnea

  1. Home
  2. Diseases
  3. Dyspnea
  4. Clinical Trials

Clinical Trials Related to Dyspnea

Related studies linked through entity extraction aliases.

NCT00505791

Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF

Status
WITHDRAWN
Phase
PHASE4

NCT00491777

Correlation Research Study: IQ2, NcIQ and IQ101

Status
COMPLETED
Phase
PHASE1

NCT00410293

NT-proBNP in Acute Dyspnea: Effects on Treatment, Hospitalisation and Costs

Status
COMPLETED
Phase
NA

NCT00338481

"Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer

Status
COMPLETED
Phase
PHASE4

NCT00327873

Palliative Oxygen for the Relief of Breathlessness

Status
COMPLETED
Phase
NA

NCT00289276

FAST (Fluid Accumulation Status Trial)

Status
COMPLETED
Phase
NA

NCT00234286

Intervention to Improve Care at Life's End

Status
COMPLETED
Phase
NA

NCT00143793

NT-proBNP and New Biomarkers in Patients With Dyspnea and/or Peripheral Edema

Status
COMPLETED
Phase
N/A

NCT00131157

Evaluation of Spirometry Expert Support in General Practice

Status
UNKNOWN
Phase
NA

NCT00130611

B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice

Status
COMPLETED
Phase
PHASE4

NCT00053846

Buspirone in Reducing Shortness of Breath in Patients With Cancer

Status
COMPLETED
Phase
PHASE2/PHASE3

NCT00043836

The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure

Status
COMPLETED
Phase
PHASE2
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.